Table 6.
Presence of validity and reliability testing of the symptom domain in instruments assessing physical symptoms.
| Measures of Validity | Measures of Reliability | |||||
|---|---|---|---|---|---|---|
| Instrument | Content | Congruent Construct |
Known Group Construct |
Responsiveness | Internal Consistency |
Test-Retest |
| Developed for Dialysis Populations | ||||||
| 100 Category Checklist | Y | Y | Y | N | Y | N |
| CHOICE Health Experience Questionnaire | Y | N | Y | N | Y | N |
| Curtin, et al.63 | Y | Y | N | N | Y | N |
| Dialysis Symptom Index | Y | N | N | N | N | Y |
| Fluid management Survey | Y | N | N | N | Y | N |
| Hemodialysis Quality of Life Questionnaire | Y | N | N | Y | N | Y |
| Kidney Disease Quality of Life Instrument | Y | Y | Y | Y | Y | |
| Kidney Disease Questionnaire | Y | Y | N | Y | Y | Y |
| Modified Edmonton Symptom Assessment System |
Y | Y | N | Y | Y | Y |
| National Kidney Dialysis and Kidney Transplantation Study |
Y | N | Y | Y | Y | Y |
| Parfrey Symptom Assessment | Y | N | Y | Y | N | N |
| Physical Symptom Distress Scale | N | Y | N | N | Y | Y |
| Short-Version Checklist | Y | Y | Y | N | Y | N |
| Developed for Nondialysis Populations | ||||||
| Bowel disease questionnaire | N | N | N | N | N | N |
| European Organization for Research and Treatment of Cancer Quality of Life Questionnaire |
N | Y | N | N | Y | N |
| McGill Quality of Life Questionnaire | N | Y | N | N | Y | Y |
| Memorial Symptom Assessment Scale | N | Y | Y | N | Y | N |
| Nottingham Health Profile | N | Y | N | Y | N | Y |
| Palliative Care Outcome Symptom Scale | N | Y | N | N | N | Y |
| Quality of Life at the End of Life | Y | Y | N | N | Y | Y |
| Quality of Well Being Self-Administered Scale | N | N | N | N | N | N |
| Rotterdam Symptom Checklist | N | Y | N | N | Y | N |
| Symptom distress scale | N | Y | Y | N | Y | Y |
Note: All psychometric measures except for content validity were deemed present if assessed quantitatively. Content validity was deemed present if a clear description of the measurement aim was provided and if dialysis patients were involved in instrument item development. Responsiveness was deemed present only if analyzed in an end-stage renal disease population.